Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2134907 | Experimental Hematology | 2006 | 11 Pages |
Abstract
These findings indicate that B-ALL has shared and strong immunogenic epitopes expressed on HLA class II molecules, the expression of which is limited to immortalized cells. These data suggest that vaccinations using DCs loaded with apoptotic tumor cells might be a potent strategy in the treatment of B-ALL.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Naoki Hatakeyama, Yasuaki Tamura, Hiroeki Sahara, Nobuhiro Suzuki, Kazuhiko Suzuki, Tsukasa Hori, Nobuo Mizue, Toshihiko Torigoe, Hiroyuki Tsutsumi, Noriyuki Sato,